American Century Companies’s Voyager Therapeutics VYGR Stock Holding History

American Century Companies's VYGR Position: Q2 2026 in Review

American Century Companies reduced its Voyager Therapeutics (VYGR) stake by 0.52% in Q2 2026, selling an estimated $2.93K and leaving 146,874 shares worth $514K. The position accounts for ﹤0.01% of the portfolio, ranked #2577.

American Century Companies first reported a position in VYGR in Q4 2018 and has held it in 19 quarters since. The position peaked at $8.06M in Q2 2024. 136 funds tracked by Wall St. Rank hold VYGR as of Q2 2026.

• American Century Companies held 146,874 shares of Voyager Therapeutics worth $514K as of Q2 2026.
• American Century Companies sold 773 Voyager Therapeutics shares in Q2 2026, an estimated $2.93K.
• Voyager Therapeutics made up ﹤0.01% of American Century Companies's portfolio in Q2 2026, its #2577 holding.
• American Century Companies first reported a position in Voyager Therapeutics in Q4 2018 and has held it in 19 quarters since.
• American Century Companies's Voyager Therapeutics position peaked at $8.06M in Q2 2024.
• 136 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q2 2026.

Based on American Century Companies's 13F filing for Q2 2026, filed 12 Aug 2026.